Huma Therapeutics completed the acquisition of Alcedis.

Huma Therapeutics, a digital health company, completed the acquisition of Alcedis, a clinical research and technology. Financial terms were not disclosed. "We are excited to be joining the Huma family, bringing our clinical trials expertise and capabilities to combine with those of Huma's award-winning technology-platform. Together, we will offer substantially greater benefit to pharmaceutical, medtech, clinical research organisation, and academic partners for their research projects," Hanno Härtlein, Alcedis Managing Director.